Summary The relationship between oral contraceptives (OCs), menopausal hormone replacement therapy (HRT) and the risk of colorectal cancer was investigated in a case-control study conducted in northern Italy between 1985 and 1992 on 709 women with incident colorectal cancer and 992 controls admitted to hospital for a wide spectrum of acute, non-neoplastic, non-digestive tract, non-hormone-related disorders. A reduced risk of colorectal cancer was observed in women who had ever used OCs (WHO, 1992) and over the last few decades its incidence and mortality trends have been consistently more favourable in women than in males in North America and in most western European countries (Ries et al., 1991; La Vecchia et al., 1992). This may be due to a healthier dietary and lifestyle pattern in women, but also to a potential protective effect of exposure to (exogenous) female hormones in women. Such an effect of female sex hormones on colorectal carcinogenesis is biologically plausible, as they influence hepatic cholesterol metabolism and bile production (McMichael and Potter, 1980) , and steroid hormone receptors have been found in colorectal cancers and normal colonic mucosa (Singh et al., 1993; Hendrickse et al., 1993). Furthermore, an inverse relationship between parity and colorectal cancer risk (Potter and McMichael, 1983) , as well as an increased incidence of colorectal cancer in nuns (Fraumeni et al., 1969), has been reported.
Cancer of the large bowel is the second leading site of cancer in women (WHO, 1992) and over the last few decades its incidence and mortality trends have been consistently more favourable in women than in males in North America and in most western European countries (Ries et al., 1991; La Vecchia et al., 1992) . This may be due to a healthier dietary and lifestyle pattern in women, but also to a potential protective effect of exposure to (exogenous) female hormones in women. Such an effect of female sex hormones on colorectal carcinogenesis is biologically plausible, as they influence hepatic cholesterol metabolism and bile production (McMichael and Potter, 1980) , and steroid hormone receptors have been found in colorectal cancers and normal colonic mucosa (Singh et al., 1993; Hendrickse et al., 1993) . Furthermore, an inverse relationship between parity and colorectal cancer risk (Potter and McMichael, 1983) , as well as an increased incidence of colorectal cancer in nuns (Fraumeni et al., 1969) , has been reported.
Several cohort and case-control studies have investigated reproductive factors and colorectal cancer in women (La Vecchia and Franceschi, 1991; Potter et al., 1993) but only few have considered use of oral contraceptives and/or hormone replacement therapy (Potter and McMichael, 1983; Wu et al., 1987; Adami et al., 1989; Chute et al., 1991; Bostick et al., 1994; Weiss et al., 1981; Rosenberg et al., 1987; Davis et al., 1989; Furner et al., 1989; Peters et al., 1990; Kune et al., 1990; Wu-Williams et al., 1991; Gerhardsson de Verdier and London, 1992; Newcomb and Storer, 1995; Jacobs et al., 1994; Risch and Howe, 1995; Calle et al., 1995; Folsom et al., 1995) . Among these, two studies have reported some (although inconsistent) increased risk of colorectal cancer among women who had used oral contraceptives (OCs) (Weiss et al., 1981; Kune et al., 1990) , and one showed a moderate protection (Potter and McMichael, 1983) . In six studies an inverse relationship was observed for hormone replacement therapy (HRT) (Chute et al., 1991; Furner et al., 1989; Gerhardson de Verdier and London, 1992; Jacobs et al., 1994; Newcomb and Storer, 1995; Calle et al., 1995) . In summary, most evidence suggests that OC and HRT use do not increase the risk of colorectal cancer, and some data even indicate a possible protective effect of HRT. Given the widespread use of OCs and HRT in developed countries, it is a major public health issue to further elucidate this relationship. Thus, this investigation was aimed at assessing the relationship between OC and HRT use and colorectal cancer, using data from a case -control study conducted in northern Italy.
Subjects and methods
The data were derived from a case -control study of colorectal cancer conducted in northern Italy, based on a network of teaching and general hospitals in the Greater Milan area (the largest urban area in northern Italy, with approximately 4 million inhabitants), and the province of Pordenone, in north-east Italy. Recruitment of colorectal cases and of the corresponding controls began in January 1985, and the present analysis is based on data collected before June 1992.
The general design of this investigation has been described previously (Negri et al., 1989; Franceschi et al., 1991 interview) cancers of the colorectum. They were admitted to the National Cancer Institute, to several university hospitals, or the Ospedale Maggiore of Milan, which includes the four largest teaching and general hospitals in Milan, to the Aviano Cancer Center and to all other general hospitals in the area of Pordenone. All the interviews were conducted in hospital, and restricted to identified surviving patients.
Controls
The comparison group included 992 women aged less than 75 years (median age, 58 years) admitted for a wide spectrum of acute, non-neoplastic, non-digestive, nonhormone-related disorders to the same network of hospitals in which cases were recruited. Forty per cent were admitted for traumatic conditions, 20% had non-traumatic orthopaedic disorders, 16% had acute surgical conditions, 13% eye conditions and 11% had other miscellaneous diseases, such as ear, nose and throat, skin, or dental disorders. About 80% of cases and controls resided in the same regions, Lombardy and Friuli Venezia-Giulia, and more than 90% came from northern Italy. As for cases, all the data were collected by direct interview during a hospital stay. Less than 3% of subjects approached (cases and controls) refused to be interviewed.
Data analysis and control for confounding Odds ratios (ORs), as estimators of relative risks, together with the corresponding 95% confidence intervals (CIs), for various measures of use of OCs and HRT were derived from unconditional multiple logistic regression equations, fitted by the method of maximum likelihood (Breslow and Day, 1980; Baker and Nelder, 1978 No interaction was apparent when the association between OCs, HRT and colorectal cancer was investigated in separate strata of age at diagnosis (<60, >60 years), menopausal status (pre, post-menopausal) and parity (0, 1 -2, > 3 births). With reference to OCs, a similar protection has been reported by some case-control studies (Potter and McMichael, 1983; Furner et al., 1989) but not in other studies (Weiss et al., 1981; Kune et al., 1990) . Further, since no consistent time-risk relationship is evident in this data set as well as in previous investigations [notably in the Nurses' Health Study cohort (Chute et al., 1991) ], some caution in the interpretation of our findings is needed.
With reference to HRT, a reduction in the risk of colorectal cancer among users has been reported by other cohort (Chute et al., 1991; Calle et al., 1995) and casecontrol studies (Furner et al., 1989; Gerhardsson de Verdier and London, 1992) . Interestingly, three other studies found an increased reduction in risk with more recent exposure (Jacobs et al., 1994; Calle et al., 1995; Newcomb and Storer, 1995) . Other studies (Potter and McMichael, 1983 Although the present investigation is the largest casecontrol study to date published on this issue, the number of cases and controls exposed is limited. The low frequency of OC and HRT use in our study population is, however, in accordance with previous estimates from the same study base population (La Vecchia et al., 1986; Parazzini et al., 1993) and consistent with available drug sales data in Italy [IMS Italia (Serra and Manna, 1992) ]. Thus, this study has limited power for detailed inspection of the influence of duration and other time factors of OCs and HRT.
The data presented here are consistent with the observation that female hormones are protective against colorectal carcinogenesis, and may be related to the hypothesis that exogenous female hormones confer a protection against colorectal cancer as a result of changes in bile acids and lipids (McMichael and Potter, 1980) . It has been postulated that the effect should be greater or limited to the right side of the colon (McMichael and Potter, 1980; Potter and McMichael, 1983; McMichael and Potter, 1985) . One limitation of the present investigation is the lack of 1434 information on specific subsites of origin of the neoplasm in the colon. However. separate analysis of colon and rectal cancer did not show appreciable differences in the risk pattern.
Further. this is a typical case-control study and. as such. has all the related limitations and strengths (Breslow and Day. 1980) . Among the strengths of the study. the comparable catchment area of cases and controls (i.e. control subjects would have been referred. if affected by colorectal cancer. to the same hospitals where cases were identified). together with the almost complete participation. are reassurinn azainst selection bias. A distortion of the observed OR towards an over-estimation of the risk cannot be disregarded. as 4000 of controls were admitted for traumatic conditions. and the use of HRT has been associated with a protectiv-e effect against osteoporotic fractures (Meyer et al.. 1993 : Hutchinson et al.. 1979 (Colombo et al.. 1977 : Kelly et al.. 1990 ).
Information bias is unlikely to have led to a sy-stematic underreporting of hormone use by cases. because a potential relationship between female hormones and colorectal cancer risk was unknown to the interviewers and probably to the subjects interviewed. With reference to confounding. the results were virtually unmodified after allowance for several covariates. including body mass index, total energy intake and other dietarv indicators. As the cases are somewhat older than the controls. it is possible that the cases had less opportunity to be treated with HRT. No temporal confounding effect b-the calendar time of advent of HRT was apparent. however. after the analy-sis in separate age strata (i.e. OR=0.31 among women aged <60 years and OR= 0.44 among woomen aged 60 for ever *s nev-er HRT use). Still. the results might be confounded owinz to the fact that w-omen using OCs and HRT have greater access to medical care and are more likely. at least in principle. to be screened for colorectal cancer. This would however have biased the observed effect towards reducing any protective effect.
From the data presented. and according to previous research McMichael. 1983: Potter et al.. 1993 
